510(k) device
Amigo Insulin Pump
Nipro Diabetes Systems, Inc. · Pump, Infusion, Insulin (LZG, Class II) · First FDA decision May 9, 2005, newest Dec 14, 2007Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
9
Naming "Amigo"
MAUDE reports
5
Brand "Amigo", since 2015
PubMed studies
170
Mentioning "Amigo"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Amigo Insulin Pump
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 2 decisions filed under this name.
- AMIGO INSULIN PUMP510(k)
K071613 · Decided Dec 14, 2007 · 184 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Insulin Infusion PumpNational analysisReview closedCAG-00041NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Amigo", any status and sponsor, newest update first.
- Urologic Lymphadenectomy in AMIGORecruiting
Brigham and Women's HospitalAcademic, hospital or other
NCT05132283 · 20 participants (planned) · Start Apr 1, 2022 · Primary completion Dec 1, 2027
Device: 3D Slicer; Monaco · For: Urologic Cancer; Lymph Node Metastasis
Sites: Boston, Massachusetts
8 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Amigo", and for the whole product code for context.
This brand
5 reports: 1 malfunction, 3 injury, 0 death
Whole product code LZG
385,399 reports: 329,529 malfunction, 55,119 injury, 355 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Amigo"[tiab]. The summary above synthesizes these.
- Adam, amigo, brain, and K channel.
Kodirov SA · Biophys Rev · 2023Review
- [Not Available].
González-Castell LD, Unar-Munguía M, Bonvecchio-Arenas A, et al. · Salud Publica Mex · 2024English Abstract
- Amigo.
Can Med Assoc J · 1968
- AMIGO-Kv2.1 Potassium Channel Complex Is Associated With Schizophrenia-Related Phenotypes.
Peltola MA, Kuja-Panula J, Liuhanen J, et al. · Schizophr Bull · 2016Research Support, Non-U.S. Gov't
- AMIGO is an auxiliary subunit of the Kv2.1 potassium channel.
Peltola MA, Kuja-Panula J, Lauri SE, et al. · EMBO Rep · 2011Research Support, Non-U.S. Gov't
- The Amigoࡊ Remote Catheter System: From Concept to Bedside.
Shaikh ZA, Eilenberg MF, Cohen TJ · J Innov Card Rhythm Manag · 2017
- AMIGO is expressed in multiple brain cell types and may regulate dendritic growth and neuronal survival.
Chen Y, Hor HH, Tang BL · J Cell Physiol · 2012Research Support, Non-U.S. Gov't
- Little amigo.
Ward D · Nursing · 2000Case Reports
- Kv2 channel-AMIGO β-subunit assembly modulates both channel function and cell adhesion molecule surface trafficking.
Maverick EE, Leek AN, Tamkun MM · J Cell Sci · 2021Research Support, N.I.H., Extramural
- AMIGO: a novel approach to the mentorship gap in pediatric rheumatology.
Nigrovic PA, Muscal E, Riebschleger M, et al. · J Pediatr · 2014Editorial
- AMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats.
Kuja-Panula J, Kiiltomäki M, Yamashiro T, et al. · J Cell Biol · 2003Research Support, Non-U.S. Gov't
- Adiós Amigo - Passing the baton.
Mohan C · Indian J Radiol Imaging · 2018Editorial
Other devices of this type
Also filed under product code LZG.
- Omnipod® Insulin Management System, Omnipod DASH® Insulin Management SystemInsulet Corporation · 510(k) 2021
- t:slim Insulin Delivery System, t:flex Insulin Delivery SystemTandem Diabetes Care, Inc. · 510(k) 2016
- Medtronic Minimed Paradigm Insulin PumpsMedtronic Minimed · 510(k) 2012
- Pivot Insulin Delivery SystemModular Medical, Inc. · 510(k) 2026
- Extended ReservoirMedtronic Minimed · 510(k) 2024
- Modular Medical MODD1 Insulin Delivery SystemModular Medical, Inc. · 510(k) 2024
- Omnipod GO Insulin Delivery DeviceInsulet Corporation · 510(k) 2023
- Omnipod DASH Insulin Management SystemInsulet Corporation · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.